Literature DB >> 28100423

Osteoarthritis year in review 2016: clinical.

N E Lane1, K Shidara2, B L Wise3.   

Abstract

Both epidemiologic and clinical research continues to be performed in osteoarthritis (OA). While epidemiologic studies identify risk factors for incident and progressive disease, clinical studies explore the role of both non-pharmacologic and pharmacologic treatments, including oral and intra-articular therapies. We performed a systematic review of the literature using PubMed for the time period between April 1, 2015 to February 22, 2016. Selected publications in the areas of both epidemiology and treatment are reviewed in this article.
Copyright © 2016. Published by Elsevier Ltd.

Entities:  

Keywords:  Epidemiology; Function; Osteoarthritis; Pain; Treatment

Mesh:

Substances:

Year:  2017        PMID: 28100423     DOI: 10.1016/j.joca.2016.09.025

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  25 in total

Review 1.  Epidemiology of osteoarthritis: literature update.

Authors:  Ernest R Vina; C Kent Kwoh
Journal:  Curr Opin Rheumatol       Date:  2018-03       Impact factor: 5.006

2.  Evaluation of the effect of polyphenol of escin compared with ibuprofen and dexamethasone in synoviocyte model for osteoarthritis: an in vitro study.

Authors:  Hossein Maghsoudi; Jamal Hallajzadeh; Mozhghan Rezaeipour
Journal:  Clin Rheumatol       Date:  2018-04-16       Impact factor: 2.980

Review 3.  Racial and ethnic differences in the pharmacologic management of osteoarthritis: rapid systematic review.

Authors:  Ernest R Vina; Philip H Tsoukas; Shahrzad Abdollahi; Nidhi Mody; Stephanie C Roth; Albert H Redford; C Kent Kwoh
Journal:  Ther Adv Musculoskelet Dis       Date:  2022-06-30       Impact factor: 3.625

4.  In Vivo Tracking of Human Adipose-derived Mesenchymal Stem Cells in a Rat Knee Osteoarthritis Model with Fluorescent Lipophilic Membrane Dye.

Authors:  Meng Li; Ming Hao; Dong Jiang; Yanxi Chen; Wen Wang
Journal:  J Vis Exp       Date:  2017-10-08       Impact factor: 1.355

5.  Value-Based Care for Nonoperative Management of Hip and Knee Osteoarthritis: Current Landscape Not Ripe for Implementation.

Authors:  Kelly R Stiegel; Melvyn A Harrington; Mohamad J Halawi
Journal:  Arthroplast Today       Date:  2021-05-15

6.  Sulforaphane protects against oxidative stress‑induced apoptosis via activating SIRT1 in mouse osteoarthritis.

Authors:  Mangmang Chen; Lipeng Huang; Yangxun Lv; Liubing Li; Qirong Dong
Journal:  Mol Med Rep       Date:  2021-06-29       Impact factor: 2.952

7.  Selection and Investigation of a Primate Model of Spontaneous Degenerative Knee Osteoarthritis, the Cynomolgus Monkey (Macaca Fascicularis).

Authors:  Gang Liu; Lei Zhang; Xin Zhou; Bao L Zhang; Guang X Guo; Ping Xu; Guo Y Wang; Shi J Fu
Journal:  Med Sci Monit       Date:  2018-07-01

8.  Wogonoside inhibits IL-1β induced catabolism and hypertrophy in mouse chondrocyte and ameliorates murine osteoarthritis.

Authors:  Qian Tang; Gang Zheng; Zhenhua Feng; Minji Tong; Jianxiang Xu; Zhiyan Hu; Ping Shang; Yu Chen; Chenggui Wang; Yiting Lou; Deheng Chen; Di Zhang; Majid Nisar; Xiaolei Zhang; Huazi Xu; Haixiao Liu
Journal:  Oncotarget       Date:  2017-06-06

9.  Intra-articular platelet-rich plasma vs corticosteroids in the treatment of moderate knee osteoarthritis: a single-center prospective randomized controlled study with a 1-year follow up.

Authors:  Andrejs Elksniņš-Finogejevs; Luis Vidal; Andrejs Peredistijs
Journal:  J Orthop Surg Res       Date:  2020-07-10       Impact factor: 2.359

10.  miR-122/SIRT1 axis regulates chondrocyte extracellular matrix degradation in osteoarthritis.

Authors:  Yinwei Bai; Kun Chen; Jianfeng Zhan; Mingxin Wu
Journal:  Biosci Rep       Date:  2020-06-26       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.